Assignment 4: Comparing and Contrasting Prescriptive Authority Requirements
Introduction
In psychiatry, prescriptive authority grants PMHNPs the right and ability to prescribe medications, including controlled substances to people with diverse mental health disorders (Moss, 2023). According to Curtis et al. (2023), prescriptive authority equips PMHNPs with the ability to prescribe medications, helping improve people’s access to care, especially in underserved regions. Besides, it helps address shortages in mental health professionals, lower patient wait time, and provide psychiatric patients with integrated care experiences. In the U.S., mental healthcare services are on a huge demand, particularly in rural and underserved areas. This necessitates the urgency to grant PMHNPs the prescriptive authority to help expand mental care access and improve treatment outcomes. For PMHNPs, prescriptive authority differs substantially across U.S states in terms scope and practice authority, regulations, and autonomy. While some states like Colorado grant full practice authority, states like New Jersey impose restrictions. This paper compares and contrasts prescriptive authority requirements between New Jersey and Colorado and how legal frameworks in respective states define PMHNPs practice and impact psychiatric care and outcomes.
Prescriptive Authority in New Jersey
The American Association of Nurse Practitioners (AANP) classifies New Jersey as a restricted practice state, implying that the autonomy of PMHNPs is limited by state laws (Joel, 2017). For PMHNPs operating in New Jersey, prescribing medications requires physician supervision. The state law and AANP clearly defines the procedure and requirements which PMHNPs must follow and comply with to obtain prescriptive authority (Stewart, 2024). First, one must obtain licensure as RN in New Jersey, complete an accredited PMHNP program from a recognized university, and obtain certification as Advanced Practice Nurse (APN). Next, New Jersey state laws requires that one applies for APN certification by submitting application to the Nursing Board with all necessary details and fees. Also, applicants must contact the American Nurses Credentialing Center (ANCC) to obtain their national certification as PMHNPs (Stewart, 2024). Once an applicant obtains the APN status, they are required to apply for CDS certificate in the state to obtain prescriptive authority. The last step is applying for a DEA certificate which grants PMHNPs full prescriptive authority.
Beyond education, certification, and licensure requirements, state laws compel PMHNPs to enter into Joint Protocol Agreements with supervising physicians. As a legally binding document, the agreement stipulates the practice scope, clinical duties, and delegation of authority between physician and PMHNPs (Sachdev et al., 2020). Besides, the supervising physician needs to be also licensed in New Jersey. Nonetheless, New Jersey imposes prescriptive authority restrictions on certain medication categories, mainly controlled drugs. As a result, PMHNPs are required to obtain a CDS registration besides the federal DEA registration to prescribe Schedule II-V medications (Joel, 2017). Despite having these limitations in place, the Joint Protocol binds these prescribing privileges, granting the supervising clinician the outright oversight.
Prescriptive Authority in Colorado
Under the AANP, Colorado is classified as a full practice authority state. This implies that PMHNPs working in Colorado are granted the right and ability independently to assess, interpret, and diagnose mental disorder test and initiate treatment plans, including medication prescription (Joel, 2017). In Colorado, the State Board of Nursing grants full practice authority. To obtain prescriptive authority in Colorado, one must first complete a graduate or post-graduate nursing program from accredited institution, complete a 750-hour mentorship with a preceptor, and possess a national certification through the ANCC (Adams et al., 2023). Also, one is required to apply for RXN-P status with the State Board of Nursing and become licensed as an APRN with a specialty in psychiatric mental health treatment.
Upon the fulfilment of these requirements, PMHNPs are entitled to apply for full practice prescriptive authority (FPA) under the Colorado Board of Nursing. Once their application is approved, PMHNPs are granted outright ability and right to independently prescribe all medication classes, including controlled drugs (Sachdev et al., 2020). However, their FPA is governed by both state and federal laws as signed during DEA registration. Also, the Colorado Board of Nursing supports independent practice privileges, where PMHNPs enjoy rights like offering telehealth psychiatry, running private clinics, and providing mental health services independently without having to establish formal agreements with supervising clinicians (Adams et al., 2023). The FPA model in Colorado improve psychiatric care access while fostering autonomy across rural and urban areas.
Compare and Contrast
In the U.S., prescriptive authority for PMHNPs is either fully granted or restricted. For example, while New Jersey restricts prescriptive authority, Colorado grants full practice authority for PMHNPs who meet the criteria. Although practice designations differ between Colorado and New Jersey, there exists similar foundational requirements for prescriptive authority for PMHNPs (Joel, 2017). First, in both New Jersey and Colorado, PMHNPs seeking prescriptive authority must first complete graduate or post-graduate psychiatric mental health education from recognized institution and obtain certification through ANCC. Also, PMHNPs must possess active RN and APRN license with respective State Board of Nursing (Sachdev et al., 2020). In addition, PMHNPs must register with DEA to be granted ability to prescribe controlled drugs.
However, there are key differences surrounding prescriptive authority between New Jersey and Colorado. For example, while PMHNPs working in New Jersey must operate under a restrictive model, PMHNPs in Colorado are not bound by this model but instead operates under a full practice model (Stewart, 2024). This implies that while PMHNPs working in New Jersey require physician guidance and collaborate to prescribe drugs, those in Colorado can prescribe medications independently provided they have completed 750 hours of mentorship and fulfilled all other requirements (Adams et al., 2023). Besides, New Jersey requires PMHNPs to establish a Joint Protocol agreement with supervising physician. However, PMHNPs in Colorado require no collaborative agreement because they can prescribe independently for all medication classes (Sachdev et al., 2020). In each state, these prescriptive authority differences have a direct impact on PMHNPs practice autonomy, practice scope, and ability to provide patient-centered psychiatric services in a timely manner and without supervisory restrictions.
Impact on Patient Care and PMHNP Role
The prescriptive authority differences significantly impact PMHNPs’ roles and quality of patient care. For example, in New Jersey, the fact that prescriptive authority is restricted causes medication access delay, potentially exposing mental health patients to further harm. According to Martin et al. (2020), the requirement that PMHNPs collaborate with physicians during medication prescription creates administrative bottlenecks and uncertainty, especially in underserved regions where there are shortages with physicians. Also, these restrictions challenge PMHNPs and make it difficult to modify medication plans hence compromising care continuity. As a result, the restrictions in New Jersey contribute to job dissatisfaction, PMHNPs burnout, and professional frustration, making them feel overwhelmed and constrained in making clinical judgement (Curtis et al., 2023). In states where the full practice model is used, like Colorado, PMHNPs are able to provide patient-centered care in a flexible and timely manner. The independent right and ability by PMHNPs to assess patients and prescribe medications without external approval improves care access in rural and underserved areas while improving quality and continuity of psychiatric services. Further, PMHNPs independence in medical prescription boosts confidence, retention, and satisfaction. Lee et al. (2021) argues that unlike in restricted states, there are more quality patient outcomes in full practice states because rapid intervention is guaranteed. The broader patient care implications for prescriptive authority include increased patient satisfaction, reduced costs of care, and higher quality outcomes.
Conclusion
State-specific laws and regulations define PMHNPs prescriptive authority which is vital in defining their practice scope, autonomy, satisfaction, and patient care quality. The rescripted practice model in New Jersey requires that PMHNPs collaborate with physicians when prescribing medications. As a result, PMHNPs working in New Jersey cannot discharge their duties independently; they must be under collaboration, supervision, or guidance by a professional physician. On the other hand, the full practice authority approved in Colorado provides PMHNPs with the ability to independently provide psychiatric care and prescribe medications without physician collaboration. Given the growing demand for psychiatry services in the U.S., there is need for expanded prescriptive authority. This will help the U.S. close gaps in healthcare while strengthening mental health care workforce. Thus, there is an urgent need to align evidence-based practice with state laws and regulations to support PMHNPs professional development and promote quality psychiatric care and outcomes.
References
Adams, A. J., Weaver, K. K., & Adams, J. A. (2023). Revisiting the continuum of pharmacist prescriptive authority. Journal of the American Pharmacists Association, 63(5), 1508 1514. https://doi.org/10.1016/j.japh.2023.06.025
Curtis, S. E., Hoffmann, S., & O’Leary Sloan, M. (2023). Prescriptive authority for psychologists: The next step. Psychological Services, 20(2), 363. https://doi.org/10.1037/ser0000667
Joel, L. A. (2017). Advanced practice nursing: Essentials for role development. FA Davis.
Lee, K. C., Silvia, R. J., Cobb, C. D., Moore, T. D., & Payne, G. H. (2021). Survey of prescriptive authority among psychiatric pharmacists in the United States. Mental Health Clinician, 11(2), 64-69. https://www.doi.org/10.9740/mhc.2021.03.064
Martin, B., Phoenix, B. J., & Chapman, S. A. (2020). How collaborative practice agreements impede the provision of vital behavioral health services. Nursing Outlook, 68(5), 581 590. https://doi.org/10.1016/j.outlook.2020.04.002
Moss, C. (2023). Prescriptive Authority. Fetal and Neonatal Pharmacology for the Advanced Practice Nurse, 17.
Stewart, T. (2024). Roles, regulations, and scope of practice. In Psychiatric-Mental Health Nurse Practitioner Program Companion and Board Certification Exam Review Workbook (pp. 1-10). Cham: Springer Nature Switzerland.